HumanexaHumanexaHumanexa
WelcomeSignalsCompaniesAssetsScenario AnalysisRegulatoryStrategy
InsightsNewslettersReportsBriefings
Pricing
WorkspaceTeamWatchlistsCollectionsSettings

Free

Intelligence Active

Regunera

FDA

Regulatory intelligence
FDAsafety guidance66% confidence

Infant Resuscitation System Correction: GE HealthCare Issues Correction for Giraffe and Panda Infant Resuscitation Systems and Warmers with M1091607-R Blender

Source: FDA

Why This Matters

Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Bayer; the same agency is already in play for this signal, so precedent weight is higher.

Regulatory Analysis

Supporting Context

Therapeutic area
Imaging · Contrast Agent
Sub-indication
General

Related signal: FDA Accepts Supplement for GADAVIST by Bayer Healthcare

Source

View source document

Related Signal

Open signal — FDA Accepts Supplement for GADAVIST by Bayer Healthcare
PrivacyTermsRefund PolicyDisclaimerContact

© 2026 Humanexa. Intelligence for research workflows — not medical, legal, regulatory filing, or investment advice.